QuidelOrtho Corporation Announces Management Appointments

Published: 2025-07-07 08:06:14 ET QDEL

Published on 07/07/2025 at 08:06

QuidelOrtho Corporation appointed two industry-leading executives to its leadership team. Devon Burek joins the Company as Senior Vice President of Global Quality, and Sergio Gadaleta joins as Senior Vice President of Clinical and Regulatory Affairs. These hires reflect the Company's continued investment in operational excellence, product quality and regulatory innovation to support global growth.

As SVP of Global Quality, Burek will lead the Company's quality organization with a focus on creating a streamlined, global approach that elevates product quality and enhances operational effectiveness. Prior to joining the Company, Burek spent over two decades at Roche in quality leadership roles across diagnostics and R&D. Gadaleta, as SVP of Clinical and Regulatory Affairs, will lead QuidelOrtho's global clinical trial strategy, regulatory submissions, and engagement with regulatory bodies, including the U.S. Food and Drug Administration ("FDA") and global health agencies. His experiences span senior roles at BD, 3M, Johnson & Johnson, and the FDA.

He holds a PhD in chemistry and is recognized for his ability to drive innovation while navigating complex global regulations.